HB-200 Arenavirus-Based Immunotherapy Plus Pembrolizumab As First-Line Treatment of Patients with Recurrent/metastatic HPV16-positive Head and Neck Cancer: Updated Results.

Alan Loh Ho,Lisle Nabell,Prakash C. Neupane,Marshall R. Posner,Emrullah Yilmaz,Jiaxin Niu,Abdul Rafeh Naqash,Alexander T. Pearson,Stuart J. Wong, Jorge J. Nieva,Douglas Earl Laux, Deborah J. L. Wong,Zujun Li,Ari Joseph Rosenberg, Winston Wong, Xiaoping Qing, Corinne Iacobucci, Henning Lauterbach,Ilian Tchakov,David G. Pfister

Journal of Clinical Oncology（2024）

Cited 0|Views17
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined